The next frontier of molecular medicine: Delivery of therapeutics

被引：321

作者：

Jain, RK ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA 02114 USA

来源：

NATURE MEDICINE | 1998年 / 4卷 / 06期

关键词：

D O I：

10.1038/nm0698-655

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Despite exciting progress in the biology underlying a variety of proposed molecular medicines, an unmet challenge Remains—delivery. This problem, how to better target the new generation of therapeutics, cuts across all diseases. The solution offers unprecedented opportunities for multidisciplinary teams of bioengineers to work with biological and medical scientists to realize the fruits of our nation's investment in molecular and cellular medicine.

引用

页码：655 / 657

页数：3

共 9 条

[1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].

Arap, W ;

Pasqualini, R ;

Ruoslahti, E .

SCIENCE, 1998, 279 (5349) :377-380

[2]

BAXTER LT, 1995, CANCER RES, V55, P4611

[3] MODULATION OF THE ORGAN MICROENVIRONMENT FOR TREATMENT OF CANCER METASTASIS [J].

FIDLER, IJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (21) :1588-1592

[4] Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].

Hanahan, D ;

Folkman, J .

CELL, 1996, 86 (03) :353-364

[5]

Jain Rakesh K., 1997, Microcirculation (Philadelphia), V4, P1, DOI 10.3109/10739689709148314

[6] Delivery of molecular medicine to solid tumors [J].

Jain, RK .

SCIENCE, 1996, 271 (5252) :1079-1080

[7] Quantitative angiogenesis assays: Progress and problems [J].

Jain, RK ;

Schlenger, K ;

Hockel, M ;

Yuan, F .

NATURE MEDICINE, 1997, 3 (11) :1203-1208

[8] A cancer therapy resistant to resistance [J].

Kerbel, RS .

NATURE, 1997, 390 (6658) :335-336

[9]

KLAUSNER RD, 1997, NATIONS INVESTMENT C

← 1 →